A fusion protein of hepatocyte growth factor for immobilization to collagen.

We describe here a fusion protein consisting of hepatocyte growth factor (HGF; an angiogenic factor) and a collagen-binding domain (CBD) polypeptide of fibronectin (FN). This fusion protein (CBD-HGF), produced by a baculovirus expression system, exhibited much stronger collagen binding activity than native HGF in the range of 0.4-6.4microg/ml. Its binding at the lowest concentration exceeded that of HGF at the highest concentration. In addition, the collagen-bound CBD-HGF promoted growth of endothelial cells (ECs) to a greater degree at least 4 days longer than HGF added to the culture medium; about 5-fold greater increase in cell number after 10 days. These findings suggest that the fused CBD moiety not only helped immobilize HGF on collagen but also helped stabilize the fusion molecule, resulting in prolonged activity. The angiogenic activity of CBD-HGF in animal tissues was examined by subcutaneously implanting collagen sponges containing bound CBD-HGF. Blood vessel formation in the sponges after 7 days was 4-6-fold extensive as compared to the control sponges without sample. Implanted sponges with native HGF did not show significant difference from control. These results indicate that CBD-HGF is suitable for in vitro culture of ECs, and that this fusion protein can be used to confer HGF activity on biomaterials for use in tissue engineering.

[1]  M. Aoki,et al.  Angiogenesis Induced by Human Hepatocyte Growth Factor Gene Impairment of Collateral Formation in Lipoprotein(a) Transgenic Mice : Therapeutic Impairment of Collateral Formation in Lipoprotein(a) Transgenic Mice Therapeutic Angiogenesis Induced by Human Hepatocyte Growth Factor Gene , 2002 .

[2]  Y. Ito,et al.  Enhancement of cell growth on growth factor-immobilized polymer film. , 1991, Biomaterials.

[3]  A. Joseph,et al.  Scatter factor binds to thrombospondin and other extracellular matrix components. , 1996, The American journal of pathology.

[4]  T. Kitajima,et al.  Production of a biologically active epidermal growth factor fusion protein with high collagen affinity. , 2001, Journal of biochemistry.

[5]  K. Tashiro,et al.  Molecular cloning and expression of human hepatocyte growth factor , 1989, Nature.

[6]  T. Nakamura,et al.  Importance of the liver in plasma clearance of hepatocyte growth factors in rats. , 1992, The American journal of physiology.

[7]  K. Matsumoto,et al.  Emerging multipotent aspects of hepatocyte growth factor. , 1996, Journal of biochemistry.

[8]  K. Matsumoto,et al.  Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease: downregulation of HGF in response to hypoxia in vascular cells. , 1999, Circulation.

[9]  Salman Rahman,et al.  Novel hepatocyte growth factor (HGF) binding domains on fibronectin and vitronectin coordinate a distinct and amplified Met-integrin induced signalling pathway in endothelial cells. , 2005, BMC cell biology.

[10]  E. Gherardi,et al.  Hepatocyte growth factor/scatter factor and MET are involved in arterial repair and atherogenesis. , 2006, The American journal of pathology.

[11]  L. Presta,et al.  Mutational analysis and molecular modeling of the N-terminal kringle-containing domain of hepatocyte growth factor identifies amino acid side chains important for interaction with the c-Met receptor. , 1994, Protein engineering.

[12]  M. Etzerodt,et al.  Collagen‐binding recombinant fibronectin fragments containing type II domains , 1994, FEBS letters.

[13]  H. Kleinman,et al.  Scatter factor induces blood vessel formation in vivo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[14]  K. Miyazawa,et al.  Molecular cloning and sequence analysis of the cDNA for a human serine protease reponsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII. , 1993, The Journal of biological chemistry.

[15]  G. Michalopoulos,et al.  Mini-review the Many Faces of Hepatocyte Growth Factor: from Hepatopoiesis to Hematopoiesis Structural Properties of Hgf the Hgf Receptor , 1995 .

[16]  N. Ohkura,et al.  Biosynthesis of recombinant human pro-alpha 1(III) chains in a baculovirus expression system: production of disulphide-bonded and non-disulphide-bonded species containing full-length triple helices. , 1995, The Biochemical journal.

[17]  Y. Ito,et al.  Protein-free cell culture on an artificial substrate with covalently immobilized insulin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Okigaki,et al.  Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. , 1989, Biochemical and biophysical research communications.

[19]  K. Matsumoto,et al.  Deletion of kringle domains or the N-terminal hairpin structure in hepatocyte growth factor results in marked decreases in related biological activities. , 1991, Biochemical and biophysical research communications.

[20]  T. Shimomura,et al.  Internalization and degradation of hepatocyte growth factor in hepatocytes with down‐regulation of the receptor/c‐Met , 1993, FEBS letters.

[21]  T. Ogihara,et al.  Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor , 1996, Journal of hypertension.

[22]  Y. Taniyama,et al.  Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease , 2001, Gene Therapy.

[23]  K. Miyazawa,et al.  Activation of hepatocyte growth factor by proteolytic conversion of a single chain form to a heterodimer. , 1992, The Journal of biological chemistry.

[24]  P. Godowski,et al.  The pharmacokinetics, tissue localization, and metabolic processing of recombinant human hepatocyte growth factor after intravenous administration in rats. , 1994, Endocrinology.

[25]  T. Nakamura,et al.  Collagens in the liver extracellular matrix bind hepatocyte growth factor. , 1998, Gastroenterology.

[26]  S. Brew,et al.  Further localization of the gelatin-binding determinants within fibronectin. Active fragments devoid of type II homologous repeat modules. , 1989, The Journal of biological chemistry.

[27]  I. Ishiwata,et al.  Establishment of HUOCA-II, a human ovarian clear cell adenocarcinoma cell line, and its angiogenic activity. , 1987, Journal of the National Cancer Institute.

[28]  L. Naldini,et al.  Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth , 1992, The Journal of cell biology.

[29]  J. Isner,et al.  Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. , 1998, Circulation.